Here's Why You Should Hold On To AngioDynamics Stock Now
Zacks Investment Research | Jan 09, 2020 07:06AM ET
AngioDynamics, Inc. (NASDAQ:ANGO) is likely to gain from a series of lucrative acquisitions and a strong view for fiscal 2020. However, headwinds in Vascular Access (“VA”) are currently plaguing the stock.
In a year’s time, shares of AngioDynamics have slipped 28.3% compared with the industry ’s 14.3% rise. Meanwhile, the S&P 500 Index has rallied 33.5%.
With a market capitalization of $578.2 million, AngioDynamics designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The company’s devices are generally used in minimally invasive, image-guided procedures. The company’s earnings are anticipated to grow 150% in the next fiscal. The trailing four-quarter positive earnings surprise is 70.6%, on average.
Let’s delve deeper into the factors that substantiate AngioDynamics’ Zacks Rank #3 (Hold) at present.
AngioDynamics, Inc. Price and Consensus
..
Cerner’s long-term earnings growth rate is 13.6%.
DexCom’s fourth-quarter earnings growth rate is projected at 31.5%.
HealthEquity’s long-term earnings growth rate is 25%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.
This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.